1230565

Regeneron Pharmaceuticals Inc — FEI 1000514603

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 22, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rensselaer, NY (United States)